Literature DB >> 7689527

Human leukocyte antigen class I-independent pathways may contribute to hepatitis B virus-induced liver disease after liver transplantation.

G Missale1, J J Brems, H Takiff, P J Pockros, F V Chisari.   

Abstract

The proliferative response of peripheral blood lymphocytes to the HBcAg was compared with serological, molecular and immunohistochemical parameters of hepatitis B virus infection and with biochemical and histological parameters of liver disease in a patient who received a completely human leukocyte antigen class I-mismatched liver allograft for fulminant hepatitis. The proliferative response increased progressively after transplantation, as hepatitis B virus infection became reestablished in the hepatic allograft. Strikingly, the HBcAg-specific T cells suddenly disappeared from the peripheral blood immediately before the acute onset of a severe necroinflammatory liver disease in which more than 80% of the hepatocytes expressed HBcAg. These observations are compatible with the hypothesis that human leukocyte antigen class I-independent hepatitis B virus-specific T cells might play a previously unsuspected role in the pathogenesis of hepatitis B virus-induced liver disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689527

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  3 in total

1.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

2.  Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.

Authors:  M J Hussain; J Y Lau; R Williams; D Vergani
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

3.  Hepatitis B virus infection associated with hematopoietic tumors.

Authors:  E Galun; Y Ilan; N Livni; M Ketzinel; O Nahor; G Pizov; A Nagler; A Eid; A Rivkind; M Laster
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.